We are live on ! Find out more
MBII

Marrone Bio Innovations, Inc.

Delisted

MBII was delisted on the 12th of July, 2022.

42 hedge funds and large institutions have $51.7M invested in Marrone Bio Innovations, Inc. in 2015 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 15 increasing their positions, 7 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

125% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 4

114% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 7

14% more funds holding

Funds holding: 3742 (+5)

6% more capital invested

Capital invested by funds: $48.6M → $51.7M (+$3.06M)

Holders
42
Holders Change
+5
Holders Change %
+13.51%
% of All Funds
1.12%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
9
Increased
15
Reduced
7
Closed
4
Calls
$1K
Puts
Net Calls
+$1K
Net Calls Change
+$8K
Name Holding Trade Value Shares
Change
Change in
Stake
WRF
1
Waddell & Reed Financial
Kansas
$18.5M
Primecap Management
2
Primecap Management
California
$12.5M
Massachusetts Financial Services
3
Massachusetts Financial Services
Massachusetts
$4.83M +$126K +33,896 +3%
SM
4
Senvest Management
New York
$4.5M +$212K +57,190 +5%
Capital Research Global Investors
5
Capital Research Global Investors
California
$2.55M
Vanguard Group
6
Vanguard Group
Pennsylvania
$1.53M +$132K +35,732 +10%
BFA
7
BlackRock Fund Advisors
California
$1.47M -$10.2K -2,758 -0.7%
Northern Trust
8
Northern Trust
Illinois
$552K
Alyeska Investment Group
9
Alyeska Investment Group
Illinois
$505K +$35.5K +9,598 +8%
SI
10
Scout Investments
Missouri
$500K
State Street
11
State Street
Massachusetts
$459K +$16.3K +4,412 +4%
PPA
12
Parametric Portfolio Associates
Washington
$430K +$30.4K +8,213 +8%
AIG
13
American International Group
New York
$423K -$3.53K -952 -0.9%
BIT
14
BlackRock Institutional Trust
California
$413K -$19.9K -5,383 -5%
Bank of New York Mellon
15
Bank of New York Mellon
New York
$357K +$78.5K +21,201 +30%
Geode Capital Management
16
Geode Capital Management
Massachusetts
$342K +$32.2K +8,707 +11%
HPCM
17
High Pointe Capital Management
Illinois
$320K -$67.1K -18,110 -18%
Deutsche Bank
18
Deutsche Bank
Germany
$272K -$83K -22,414 -24%
TCIM
19
TIAA CREF Investment Management
New York
$170K
BIM
20
BlackRock Investment Management
Delaware
$156K
Mackenzie Financial
21
Mackenzie Financial
Ontario, Canada
$155K +$148K +40,000 New
JPTCCM
22
J.P. Turner & Co Capital Management
Georgia
$138K +$129K +34,800 New
TA
23
Teachers Advisors
New York
$108K +$15.5K +4,190 +18%
California State Teachers Retirement System (CalSTRS)
24
California State Teachers Retirement System (CalSTRS)
California
$99K
Charles Schwab
25
Charles Schwab
California
$66K

MBII Hedge Fund Activity: Q1 2015 in Review

42 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Marrone Bio Innovations, Inc. (MBII) for Q1 2015, worth a combined $51.7M — up 6.3% from $48.6M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new MBII positions and 4 closed out — a net gain of 5 holders — while 15 added to existing stakes and 7 trimmed.

The largest buyer was Senvest Management, adding an estimated $212K. The largest seller was AWM Investment Company, exiting entirely with an estimated $1.14M sold.

  • 42 institutional investors held Marrone Bio Innovations, Inc. (MBII) as of Q1 2015, up from 37 in Q4 2014.
  • Funds reported $51.7M of Marrone Bio Innovations, Inc. stock for Q1 2015, up 6.3% quarter-over-quarter.
  • 9 funds opened new Marrone Bio Innovations, Inc. positions in Q1 2015 and 4 closed out, a net change of +5 holders.
  • The largest Marrone Bio Innovations, Inc. buyer in Q1 2015 was Senvest Management, an estimated $212K added.
  • The largest Marrone Bio Innovations, Inc. seller in Q1 2015 was AWM Investment Company, an estimated $1.14M sold.

Based on aggregated 13F filings for Q1 2015.